159 related articles for article (PubMed ID: 17507113)
1. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression.
Kiss JP
Neurochem Int; 2008 Jan; 52(1-2):34-9. PubMed ID: 17507113
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological properties of antidepressants.
Racagni G; Popoli M
Int Clin Psychopharmacol; 2010 May; 25(3):117-31. PubMed ID: 20305568
[TBL] [Abstract][Full Text] [Related]
4. Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review.
Morishita S
Hum Psychopharmacol; 2009 Apr; 24(3):191-8. PubMed ID: 19330803
[TBL] [Abstract][Full Text] [Related]
5. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target.
Lader M
Eur Neuropsychopharmacol; 2007 Dec; 17(12):743-55. PubMed ID: 17624740
[TBL] [Abstract][Full Text] [Related]
6. Expanding the horizons of depression: beyond the monoamine hypothesis.
Hindmarch I
Hum Psychopharmacol; 2001 Apr; 16(3):203-218. PubMed ID: 12404573
[TBL] [Abstract][Full Text] [Related]
7. [New options in the treatment of depression].
Frieling H; Hillemacher T; Demling JH; Kornhuber J; Bleich S
Fortschr Neurol Psychiatr; 2007 Nov; 75(11):641-52. PubMed ID: 17366379
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant action of tianeptine is connected with acceleration of serotonin turnover in the synapse: a hypothesis.
Uzbekov MG
Neuropsychopharmacol Hung; 2009 Jun; 11(2):83-7. PubMed ID: 19827315
[TBL] [Abstract][Full Text] [Related]
9. Differentiating antidepressants of the future: efficacy and safety.
Rosenzweig-Lipson S; Beyer CE; Hughes ZA; Khawaja X; Rajarao SJ; Malberg JE; Rahman Z; Ring RH; Schechter LE
Pharmacol Ther; 2007 Jan; 113(1):134-53. PubMed ID: 17010443
[TBL] [Abstract][Full Text] [Related]
10. Monoamine specificity of antidepressants and prediction of therapeutic response.
Balon R
Encephale; 1991; 17 Spec No 1():121-2. PubMed ID: 1864258
[TBL] [Abstract][Full Text] [Related]
11. [Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems].
Cassano P; Argibay P
Medicina (B Aires); 2010; 70(2):185-93. PubMed ID: 20447905
[TBL] [Abstract][Full Text] [Related]
12. [Monoaminergic theories in depressive illness (author's transl)].
Zarifian E
Ann Biol Clin (Paris); 1979; 37(1):21-6. PubMed ID: 443609
[TBL] [Abstract][Full Text] [Related]
13. Deltamethrin, a pyrethroid insecticide, could be a potential antidepressant agent.
Tsai SJ
Med Hypotheses; 2006; 66(3):605-8. PubMed ID: 16310970
[TBL] [Abstract][Full Text] [Related]
14. [Advances in the molecular treatment of depression].
Páez X; Hernández L; Baptista T
Rev Neurol; 2003 Sep 1-15; 37(5):459-70. PubMed ID: 14533097
[TBL] [Abstract][Full Text] [Related]
15. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system.
Pharmacol Rev; ; . PubMed ID: 10699155
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
